Company Overview

Development Stage

About the Company

[Summary] 一家临床阶段的全球性生物制药公司

关于阿诺医药
阿诺医药(纳斯达克股票代码:ANL)是一家临床阶段的全球性生物制药公司,专注于“全球新”肿瘤药物研发,在中美两地均设有研发及临床运营中心。公司集结了经验丰富的领导和研发团队,建立了差异化的肿瘤产品管线,并与多家知名头部制药公司合作,加速药物发现和开发。 我们致力于成为打造“全球新”肿瘤药物的创新型研发企业,以更优良的治疗方式惠及中国乃至全球患者。

依托中美双中心研发布局,我们已构建起一条聚焦两个核心领域的有影响力的研发管线: ①RAS驱动肿瘤的靶向治疗策略:包括AN9025(口服泛RAS(ON) 抑制剂),以及AN4035(靶向 CEACAM5 的新型ADC,将高效泛 RAS(ON) 抑制剂精准递送至肿瘤);②下一代肿瘤免疫疗法:包括 AN8025(由 αPD-L1 × CD86 变体 × LAG3 变体构成的三功能融合蛋白,调节 T 细胞与抗原呈递细胞),以及AN4005(口服小分子 PD-L1 抑制剂)。
欲了解更多,请访问*。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

阿诺医药 Financing History (5 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

阿诺医药 How Fast Is Hiring Growing? (20 open positions)

Manage
Note: How fast is hiring at 杭州阿诺生物医药科技有限公司 growing? 阿诺医药2025: 9 openings (down 59%), 2024: 22 openings (down 58%), 2023: 53 openings (up 194%), 2022: 18 openings (down 79%), 2021: 87 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

阿诺医药 Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
阿诺医药 Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 杭州阿诺生物医药科技有限公司 growing? 阿诺医药Master's recruitment over the years: 2026: 16 openings (up 300%), 2024: 3 openings (down 58%), 2023: 9 openings (up 194%), 2022: 2 openings (down 79%), 2021: 8 openings.

阿诺医药 Doctoral Degree Job Demand Analysis

(More)
+25%
Growth Rate
2026 vs 2025
  • 2025: Down 73%
  • 2024: Down 25%
  • 2023: Up 122%
  • 2022: Up 800%
阿诺医药 Doctoral Hiring by Year: 2026 — 1 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 杭州阿诺生物医药科技有限公司 growing? 阿诺医药Doctorate recruitment over the years: 2026: 5 openings (up 25%), 2025: 4 openings (down 73%), 2024: 15 openings (down 25%), 2023: 20 openings (up 122%), 2022: 9 openings (up 800%), 2021: 1 openings.

阿诺医药 — What Are the Salaries Like? (22 records)

Manage
阿诺医药 Salary Overview
salary range: 3K - 50K, 63.6% of roles pay ¥10-30K
Note: salary statistics are based on 22 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 杭州阿诺生物医药科技有限公司?阿诺医药63.6% of positions earn 10-30K, Undergraduate salary: ¥。Hangzhou salary ranking: #638,财务/审计/统计类 average salary ¥10.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 阿诺医药

(More)
Are salaries high at 杭州阿诺生物医药科技有限公司? We provide: pm,临床,科学家,财务,实习生,研究员,项目管理,bi,cs,ie,ios,ma,statistician,会计,出纳,副总,化学,总账,投资者关系,招聘经理. Click to view detailed salary analysis by job.

阿诺医药 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

阿诺医药 Related Industry Tags

Job Category

  • 财务/审计/统计类
    29.7% of total 29.7%
  • 医疗卫生/美容保健类
    27% of total 27%
  • 生物/制药/化工/环保类
    27% of total 27%
  • 科研类
    24.3% of total 24.3%

Education

  • 硕士
    45.9% of total 45.9%
  • 本科
    35.1% of total 35.1%
  • 博士
    13.5% of total 13.5%
  • 大专
    2.7% of total 2.7%

Experience

  • 不限
    45.9% of total 45.9%
  • 3-5年
    27% of total 27%
  • 5-10年
    16.2% of total 16.2%
  • 1-3年
    10.8% of total 10.8%
View Detailed Analysis

What does 杭州阿诺生物医药科技有限公司 require? Who is 阿诺医药 hiring? 阿诺医药 recruitment: 财务/审计/统计类占比最多占29.7%,其次是医疗卫生/美容保健类占27%. What education can get in at 阿诺医药? 硕士占比最多占45.9%,其次是本科占35.1%. High education required at 阿诺医药? 硕士占45.9%,博士占13.5%. Work experience required at 阿诺医药? 不限占比最多占45.9%,其次是3-5年占27%. Where are the job locations at 阿诺医药? 杭州占比最多占83.8%,其次是上海占10.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 20,000万(元)
Legal Representative: 路杨
Date Established:
Credit Code: 9133010176547745XB
Registered Address: 浙江省仓前街道向往街1008号8幢

Partners & Suppliers

百时美施贵宝提供Opdivo用于阿诺医药AN2025联合疗法的临床试验 Source
供应商 临床试验合作
默沙东提供Keytruda用于阿诺医药AN2025联合疗法的临床试验 Source
供应商 临床试验合作
阿诺医药获得诺华旗下buparlisib(AN2025)的全球独家许可 Source
供应商 技术授权/专利交叉许可
为阿诺医药提供抗体药物研发与生产服务 Source
供应商 CRO/CDMO

People who follow 阿诺医药 also follow

阿诺医药 Competitors (Similar Companies)

“让原创药禧济天下”
生物科技/生物工程 生物制剂 药物研发 生物医药
转化医学 再生医学 生物材料 科研仪器
“合成生物学技术开发商”
分子诊断 基因测序 体外诊断/IVD 医学诊断
新材料 聚乙烯/PE 化工/化学 塑料合金
精密机械零部件 机械零部件 生产 机械五金加工
服装/服饰 纺织 丝绸 化纤面料
工程设计 建筑幕墙 机电设备安装 门窗
品牌策划 艺术涂料 墙面装饰产品 代理分销
离心泵 多级离心泵 自动化 生产
开关电源 变电站 直流/DC电源 电力
造纸/造纸厂/纸业 打印纸 文化用纸 双面胶
模具 模具设计 模具开发 硅胶
塑胶零件 塑胶零配件 眼镜 配件

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates